These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

203 related items for PubMed ID: 17517840

  • 1. Measurement of voriconazole activity against Candida albicans, C. glabrata, and C. parapsilosis isolates using time-kill methods validated by high-performance liquid chromatography.
    Li Y, Nguyen MH, Derendorf H, Cheng S, Clancy CJ.
    Antimicrob Agents Chemother; 2007 Aug; 51(8):2985-7. PubMed ID: 17517840
    [Abstract] [Full Text] [Related]

  • 2. Characterizing the effects of caspofungin on Candida albicans, Candida parapsilosis, and Candida glabrata isolates by simultaneous time-kill and postantifungal-effect experiments.
    Clancy CJ, Huang H, Cheng S, Derendorf H, Nguyen MH.
    Antimicrob Agents Chemother; 2006 Jul; 50(7):2569-72. PubMed ID: 16801448
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Reliability of the Vitek 2 yeast susceptibility test for detection of in vitro resistance to fluconazole and voriconazole in clinical isolates of Candida albicans and Candida glabrata.
    Posteraro B, Martucci R, La Sorda M, Fiori B, Sanglard D, De Carolis E, Florio AR, Fadda G, Sanguinetti M.
    J Clin Microbiol; 2009 Jun; 47(6):1927-30. PubMed ID: 19403774
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Pharmacokinetic/pharmacodynamic modelling and in vitro simulation of dynamic voriconazole-Candida interactions.
    Li Y, Nguyen MH, Schmidt S, Zhong L, Derendorf H, Clancy CJ.
    Int J Antimicrob Agents; 2009 Sep; 34(3):240-5. PubMed ID: 19339162
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Frequency of voriconazole resistance in vitro among Spanish clinical isolates of Candida spp. According to breakpoints established by the Antifungal Subcommittee of the European Committee on Antimicrobial Susceptibility Testing.
    Cuenca-Estrella M, Gomez-Lopez A, Cuesta I, Zaragoza O, Mellado E, Rodriguez-Tudela JL, Antifungal Subcommittee of European Committee on Antimicrobial Susceptibility Testing.
    Antimicrob Agents Chemother; 2011 Apr; 55(4):1794-7. PubMed ID: 21282420
    [Abstract] [Full Text] [Related]

  • 11. [In vitro activity of fluconazole, voriconazole and posaconazole against Candida spp].
    Rubio Calvo MC, Gil J, Ramírez de Ocáriz I, Benito R, Rezusta A.
    Rev Esp Quimioter; 2003 Jun; 16(2):227-32. PubMed ID: 12973462
    [Abstract] [Full Text] [Related]

  • 12. Comparison of antifungal susceptibilities to fluconazole and voriconazole of oral Candida glabrata isolates from head and neck radiation patients.
    Burn AK, Fothergill AW, Kirkpatrick WR, Coco BJ, Patterson TF, McCarthy DI, Rinaldi MG, Redding SW.
    J Clin Microbiol; 2004 Dec; 42(12):5846-8. PubMed ID: 15583322
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Postantifungal effect of the combination of caspofungin with voriconazole and amphotericin B against clinical Candida krusei isolates.
    Oz Y, Kiremitci A, Dag I, Metintas S, Kiraz N.
    Med Mycol; 2013 Jan; 51(1):60-5. PubMed ID: 22746405
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Emergence of Candida albicans fungemia during voriconazole therapy.
    Mohammedi I, Thiebaut A, Piens MA, Argaud L, Martin O, Robert D.
    J Infect; 2005 Oct; 51(3):e83-4. PubMed ID: 16230209
    [No Abstract] [Full Text] [Related]

  • 18. Triazole cross-resistance among Candida spp.: case report, occurrence among bloodstream isolates, and implications for antifungal therapy.
    Magill SS, Shields C, Sears CL, Choti M, Merz WG.
    J Clin Microbiol; 2006 Feb; 44(2):529-35. PubMed ID: 16455909
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.